Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03256760 · ClinicalTrials.gov registry record · Phase 1
Sleep and Healthy Aging Research for Depression (SHARE-D) Study
A Phase 1 study, sponsored by Michael Irwin, MD.
- Completed
- Registry status
- Phase 1
- Development phase
- 160
- Enrollment target
NCT03256760 is a Phase 1 study that has completed, run by Michael Irwin, MD. The registered enrollment target is 160 participants.
The verdict
NCT03256760, a Phase 1 study, has completed, sponsored by Michael Irwin, MD.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 160 participants
- Enrollment target
Study Summary
Late-life depression is a significant public health concern, and effective interventions for prevention and treatment are needed. Insomnia and inflammation are modifiable targets for depression prevention, and this study is significant in using an experimental approach (i.e., inflammatory challenge) to probe acute inflammatory- and depression responses as a function of insomnia, which will inform identification of molecular targets for pharmacologic interventions, and improvement of insomnia treatments to prevent depression in older adults. Project
Interventions
- BIOLOGICAL Placebo
- BIOLOGICAL Endotoxin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2017-08-23 |
| Est. Completion | 2024-04-30 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03256760
The ClinicalTrials.gov registry entry for NCT03256760 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 160 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Michael Irwin, MD, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT03256760 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03256760 about?
NCT03256760 is a clinical study titled "Sleep and Healthy Aging Research for Depression (SHARE-D) Study". Late-life depression is a significant public health concern, and effective interventions for prevention and treatment are needed. Insomnia and inflammation are modifiable targets for depression prevention, and this study is significant in using an experimental approach (i.e., inflammatory challenge)...
What is the current status of trial NCT03256760?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 160 participants. The study started on 2017-08-23. Estimated completion is 2024-04-30.
What interventions are being tested in trial NCT03256760?
The interventions under investigation include: Placebo (BIOLOGICAL), Endotoxin (BIOLOGICAL).
Who is sponsoring clinical trial NCT03256760?
This trial is sponsored by Michael Irwin, MD, which has 1 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.